These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protein AA amyloidosis in Nigeria. MacIver AG; Thomas SM J Trop Med Hyg; 1982 Oct; 85(5):209-12. PubMed ID: 7176004 [TBL] [Abstract][Full Text] [Related]
3. Correspondence re: T. Ohyama, T. Shimokama, Y. Yoshikawa et al. Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features. Mod Pathol 3:419, 1990. Buck FS; Koss MN Mod Pathol; 1992 Jan; 5(1):97. PubMed ID: 1542642 [No Abstract] [Full Text] [Related]
4. A serum AA-like protein as a common constituent of secondary amyloid fibrils. Westermark P; Sletten K Clin Exp Immunol; 1982 Sep; 49(3):725-31. PubMed ID: 7172504 [TBL] [Abstract][Full Text] [Related]
5. [Current aspects of the etiopathogenesis and therapy of amyloid disease: future trends]. Scheinberg MA Rev Paul Med; 1980; 96(5-6):108-11. PubMed ID: 6784226 [No Abstract] [Full Text] [Related]
9. [A study of amyloidogenesis in relation to SAA levels in inflammatory diseases]. Tomita M; Isobe T; Matsumoto J; Fujita T Ryumachi; 1985 Apr; 25(2):110-4. PubMed ID: 4035466 [No Abstract] [Full Text] [Related]
10. [Amyloidosis. I. Recent findings concerning amyloid substance]. Lovisetto P; Gilardi E; Frascisco M; Marchi L; Mairano D Minerva Med; 1980 Jun; 71(25):1793-800. PubMed ID: 6997780 [TBL] [Abstract][Full Text] [Related]
11. Amyloid A in systemic amyloidosis associated with cancer. Husby G; Marhaug G; Sletten K Cancer Res; 1982 Apr; 42(4):1600-3. PubMed ID: 7060030 [TBL] [Abstract][Full Text] [Related]
12. [Systemic amyloidosis in Behçet's disease]. Cases A; Martos JA; Montoliu J; Moreno A; Revert L Med Clin (Barc); 1987 Jul; 89(6):250-2. PubMed ID: 3626689 [No Abstract] [Full Text] [Related]
13. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis. Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566 [TBL] [Abstract][Full Text] [Related]
15. [Amyloidosis. II. Current pathogenetic and clinico-nosographic aspects]. Lovisetto P; Frascisco M; Gilardi E; Marchi L; Mairano D Minerva Med; 1980 Jun; 71(25):1801-13. PubMed ID: 6774298 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic amyloidosis in the stone marten (Martes foina): identification of amyloid fibril proteins in tissue sections using the immunoperoxidase technique. Linke RP; Geisel O; Eulitz M; Nathrath WB Blut; 1980 Dec; 41(6):465-8. PubMed ID: 7004540 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of amyloid in murine and human secondary amyloidosis by the immunoperoxidase technique. Livni N; Laufer A; Levo Y J Pathol; 1980 Dec; 132(4):343-8. PubMed ID: 7003080 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic modalities in systemic amyloidosis. van Gameren I Amyloid; 2010 Jun; 17(2):94. PubMed ID: 20196637 [No Abstract] [Full Text] [Related]
19. Is amyloid A (AA) amyloidosis always secondary? Maury CP; Törnroth T; Wegelius O Ann Rheum Dis; 1985 Apr; 44(4):273-6. PubMed ID: 3985695 [TBL] [Abstract][Full Text] [Related]
20. [Recent advances in studies on amyloid and amyloidosis (author's transl)]. Uchino F Nihon Ika Daigaku Zasshi; 1981 Apr; 48(2):160-8. PubMed ID: 7028778 [No Abstract] [Full Text] [Related] [Next] [New Search]